A recent Wall Street Journal article revealed that President Donald Trump discussed reclassifying marijuana at a high-dollar fundraising event — a move that profit-driven cannabis corporations are aggressively pushing.
These businesses have poured millions into political campaigns, eyeing lucrative federal tax breaks and business advantages that rescheduling would unlock. Their goal is clear: expand profits and continue to advance the unfettered commercialization of ultrapotent products that can bear little resemblance to what many people think about as marijuana.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.